Swissquote launched the Innovation Money Makers Index at the end of April 2026. What the companies included have in common is that they pass the same capital-related test in very different markets: they make money from innovation. The current weighting demonstrates how much the top end of the index is dominated by US big tech and digital infrastructure at the moment. Alphabet, Amazon, Broadcom and Nvidia are particularly highly weighted, followed by Meta, Microsoft and ASML. The fabled Magnificent 7 world has a significant presence, then, and there is a clear European outlier in ASML. The company is the only European firm in the leading group. And not without reason: structurally the Dutch company is almost indispensable in the semiconductor universe because its EUV systems are what make it possible to mass-produce the most advanced chips in the first place. Nvidia fits the bill for the same reason: having helped to launch the modern AI era with the GPU, the company is now a full-stack infrastructure platform for accelerated computing.<\/p>\n\n
It is not just tech groups that feature in the new barometer: innovative companies can be found in many other sectors as well. They include the Swiss ABB, which again represents the industrial side of the theme with electrification, automation and a robotics division. Caterpillar brings innovation in heavy industry on the road and in opencast mining. The company boasts one of the world\u2019s largest and most tried-and-tested autonomous mining fleets. Rolls-Royce is not another classic tech stock either, but a high-tech provider for drivetrains and energy systems. It also uses digital twins, precisely the kind of engineering innovation that thrives not on vision, but rather on contracts and service revenue.<\/p>\n\n
The same principle applies in the healthcare sector. With its Da Vinci systems, Intuitive Surgical is one of the pioneers of robot-assisted surgery, combining robotics with software, data and recurring revenue in everyday clinical practice. The company has set itself the goal of making surgical procedures more effective, less invasive and more pleasant for surgeons, patients and their relatives. For its part, Johnson & Johnson shows that innovation is not restricted to Silicon Valley: in the medtech sector, the group operates at the interface of biology and technology, focusing on the fields of cardiovascular medicine, orthopaedics, surgery and ophthalmology.<\/p>\n\n
Companies which translate technical innovations into marketable products, platforms and services thus make up the DNA of the Swissquote Innovation Money Makers Index. It is precisely this transition from technological progress to commercial success that the Swissquote Innovation Money Makers Index focuses on. The new tracker certificate from Leonteq gives investors convenient access to the promising concept. The participation product fully reflects the price movements of the underlying index, less charges. The costs comprises a management fee of 1.00% p.a., a calculation agent fee of 0.20% p.a. and a transaction fee of up to 0.10%. The certificate does not have a fixed term, so investors are free to choose their own investment horizon.<\/p>\n\n\n
We look forward to answering all of your questions about our products and how they are traded. Please don't hesitate to get in touch! Phone: 058 800 11 11<\/a>, email info@leonteq.com<\/a> or contact us here<\/a>.\n<\/p>\n <\/div>","url":"swissquote-innovation-money-makers-index","investmentThemeVerticalImageUrl":"https://structuredproducts-ch.leonteq.com/product-news/sidenav-banner/sq_innovation+money+makers+index_leonteq-structured-products_sidenav+banner.jpg","thumbnailUrl":"https://structuredproducts-ch.leonteq.com/product-news/thumbnail/sq_innovation+money+makers+index_leonteq-structured-products_thumbnail.jpg"}